The blood thyroglobulin level in papillary thyroid carcinoma and blood calcitonin and carcinoembryonic antigen level in medullary carcinoma are useful biomarkers for the evaluation of disease activity, but no effective biomarker has been established for squamous cell carcinoma. This evidence concerns the gene CEACAM5 and squamous cell carcinoma.